87Trust
Verified
🔍 Web Verified🏛 Established Source (T2)
u/DragonPuponReddit1d ago
Pancreatic cancer mRNA vaccine shows lasting results in an early trial
Trust Metrics
88
92
85
80
Claim Accuracy88%
Source Quality92%
Framing & Tone85%
Context80%
Analysis Summary
A personalized mRNA pancreatic cancer vaccine tested in a small Phase 1 trial kept seven of eight patients who responded to it alive for six years — far better than the typical 13% five-year survival rate for pancreatic cancer. The vaccine works by training the immune system to hunt down remaining cancer cells after surgery; patients also received standard chemotherapy. The trial results, presented this week at a major cancer research conference, suggest the approach could work for one of the deadliest cancers, though researchers caution these are early findings from a 16-person trial and larger Phase 2 and Phase 3 studies are needed to confirm effectiveness and safety.
Claims Analysis (4)
“Pancreatic cancer mRNA vaccine shows lasting results in an early trial”
NBC News published results from Phase 1 clinical trial with six-year follow-up data presented at AACR annual meeting April 21, 2026. Core finding confirmed by multiple sources.
“Nearly all of the patients who responded to the personalized vaccine are still alive six years later”
Article states 7 of 8 responders still alive at six-year mark. Gustafson and six others confirmed alive; two non-responders also alive. Framing 'nearly all' is accurate.
“Less than 13% of people diagnosed with pancreatic cancer live for more than five years”
Cited directly in article from clinical trial documentation. Standard survival statistic for pancreatic cancer supported by oncology literature.
“The most important finding here is that the people who mount a response to the vaccine live longer than those who do not”
Direct quote from Dr. William Freed-Pastor in the published article. Reflects the primary outcome of the trial analysis.
Was this analysis helpful?
Try ClearFeed free →